Enlivex Announces a new publication “Apoptotic cell therapy for cytokine storm associated with acute severe sepsis” in Cell Death & Disease, a Nature Research Journal

    NEXT STORY
    Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
    PREV STORY
    UV-Concepts Announces Launch of UV-C Enclosure (UVE™), The First and Only Automated UV Light Disinfection Solution for Portable Medical Equipment
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Poseida Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed/Refractory Multiple Myeloma

    Efficacy and safety continue to be a major advantage, with a very high response ...

    author_avatar
    NASDAQ Market News

    GILEAD AND GALAPAGOS ANNOUNCE RESULTS WITH FILGOTINIB IN THE PHASE 2 EQUATOR STUDY IN PSORIATIC ARTHRITIS AND PROGRESSION INTO PHASE 3 FOR THE SELECTION STUDY IN ULCERATIVE COLITIS

    -- EQUATOR Achieves Primary Endpoint of ACR20 Response at Week 16 -- -- Galapagos ...

    author_avatar
    NASDAQ Market News

    Entasis Therapeutics Announces Multiple Data Presentations at ECCMID 2019

    author_avatar
    NASDAQ Market News